This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
0,01250 €
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)
Categories
Athersys (ATHX) - Total assets
Total assets on the balance sheet as of September 2023 : €6.87 Million
According to Athersys's latest financial reports the company's total assets are €6.87 Million. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Athersys - Total assets on balance sheet (from 2005 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | €25.85 M | -51.35% |
| 2021-12-31 | €53.14 M | 9.46% |
| 2020-12-31 | €48.54 M | 30.53% |
| 2019-12-31 | €37.19 M | -31.07% |
| 2018-12-31 | €53.96 M | 92.73% |
| 2017-12-31 | €27.99 M | 54.51% |
| 2016-12-31 | €18.12 M | -21.16% |
| 2015-12-31 | €22.98 M | -2.67% |
| 2014-12-31 | €23.61 M | -4.62% |
| 2013-12-31 | €24.75 M | 18.63% |
| 2012-12-31 | €20.86 M | 72.6% |
| 2011-12-31 | €12.09 M | -15.83% |
| 2010-12-31 | €14.36 M | -27.36% |
| 2009-12-31 | €19.77 M | -18.4% |
| 2008-12-31 | €24.23 M | -32.25% |
| 2007-12-31 | €35.76 M | |
| 2006-12-31 | N/A | -100% |
| 2005-12-31 | €0 M | 14.51% |
| 2004-12-31 | €0 M | -100% |
| 2003-12-31 | €24.22 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | €85.02 B | 1,236,289.34% | 🇺🇸 USA |
 | €197.57 B | 2,872,759.45% | 🇺🇸 USA |
 | €85.73 B | 1,246,574.74% | 🇺🇸 USA |
 | €13.09 B | 190,287.72% | 🇺🇸 USA |
 | €166.74 B | 2,424,563.44% | 🇺🇸 USA |
 | €0.50 B | 7,212.37% | 🇺🇸 USA |
 | N/A | N/A | 🇺🇸 USA |
 | €108.42 B | 1,576,448.20% | 🇺🇸 USA |
 | €127.94 B | 1,860,320.03% | 🇫🇷 France |